<DOC>
	<DOCNO>NCT03087955</DOCNO>
	<brief_summary>The goal study assess efficacy safety SCYX-7158 give single dose oral treatment adult patient ( equal 15 ) fast state T.b . Gambiense HAT</brief_summary>
	<brief_title>Prospective Study Efficacy Safety SCYX-7158 Patients Infected Human African Trypanosomiasis Due T.b . Gambiense</brief_title>
	<detailed_description />
	<mesh_term>Trypanosomiasis , African</mesh_term>
	<mesh_term>Trypanosomiasis</mesh_term>
	<criteria>Male female patient 15 year age older Signed informed consent form ( well assent illiterate underage patient , unable give consent ) Karnofsky Performance Status 50 Able ingest oral tablet Having permanent address traceable person Able comply schedule followup visit requirement study Agreement hospitalise order receive treatment For patient latestage HAT : Confirmation gHAT detection parasite blood and/or lymph and/or CSF , investigational centre If trypanosomes find blood lymph , CSF , CSF WBC , measure investigational centre , must 20/μL patient include cohort patient latestage HAT For patient early intermediatestage HAT : Confirmation gHAT detection parasite blood and/or lymph , investigational centre Absence parasites CSF The CSF WBC , measure investigational centre , must 6 20/μL patient include cohort patient intermediatestage HAT equal 5/μL patient include cohort patient earlystage HAT . Severe malnourishment , define bodymass index ( BMI ) 16 Pregnancy breastfeeding ( woman childbearing potential , confirmed pregnancy urine pregnancy test perform within 24 hour prior administration SCYX7158 ) Clinically significant medical condition could , opinion Investigator , jeopardise patient 's safety interfere participation study , include , limited significant liver cardiovascular disease , suspect proven active infection , central nervous system trauma seizure disorder , coma consciousness disturbance Severely deteriorate health status , e.g . due cardiovascular shock , respiratory distress syndrome endstage disease Previously treat HAT ( except prior treatment pentamidine ) Prior enrolment study Foreseeable difficulty comply followup , include migrant worker , refugee status , itinerant trader etc . Current alcohol abuse drug addiction Not test malaria and/or receive appropriate treatment malaria Not receive appropriate treatment soiltransmitted helminthiasis Clinically significant abnormal laboratory value include Aspartate AminoTransferase ( AST ) and/or AlanineAminoTransferase ( ALT ) 2 time upper limit normal ( ULN ) , total bilirubin 1.5 ULN , severe leukopenia less 2000/mm3 , Potassium 3.5 mmol/L , clinically significant abnormal laboratory value</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>